Bradley JS, Byington CL, Shah SS, et al. The management of Community-acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011:53:e25–76.

Article  PubMed  Google Scholar 

Chen HL, Chiou SS, Hsiao HP, et al. Respiratory adenoviral infections in children: a study of hospitalized cases in southern Taiwan in 2001–2002. J Trop Pediatr. 2004;50:279–84.

Article  PubMed  Google Scholar 

Kato S, Yoshimura K, Tanabe Y, et al. A child with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis complicated by coronary artery lesion mimicking kawasaki disease. J Pediatr Hematol Oncol. 2013;35:317–9.

Article  Google Scholar 

Eloseily EM, Weiser P, Crayne CB, et al. Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis. Arth Rheumatol. 2020;72:326–34.

Article  CAS  Google Scholar 

Rajasekaran S, Kruse K, Kovey K, et al. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children. Pediatr Critic Care Med. 2014;15:401–8.

Article  Google Scholar 

Baverez C, Grall M, Gerfaud-Valentin M, et al. Anakinra for the treatment of hemophagocytic lymphohistiocytosis: 21 cases. J Clin Med. 2022;11:5799.

Article  CAS  PubMed  PubMed Central  Google Scholar